ArticleNucleic acid therapeutics2022

Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives.

Matthis Synofzik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.